Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells

作者：Che, Wen; Bao, Yun; Tang, Feng^*

来源：PLos One, 2017, 12(8): e0183941.

DOI：10.1371/journal.pone.0183941

• CANCER CELLS
• TARGETED THERAPIES
• SIGNALING PATHWAY
• GENE-EXPRESSION
• APOPTOSIS
• SURVIVAL
• MCF-7
• INHIBITION
• ACTIVATION
• AMPLICON

Background @@@ Resistance to human epidermal growth factor receptor-2 (HER2)-targeted therapies is common, and results in treatment failure and new tumor progression. C35 is over-expressed in many invasive breast cancer endogenously, and functions as an oncogene in breast cancer cell lines. @@@ Methods @@@ The current study aims to investigate effects of C35 on cell viability and migration of HER2-positive breast tumor cells and explore possible mechanisms. The protein expression of C35 in BT-474 breast ductal carcinoma cells was interfered by siRNAs. MTT assay was utilized to detect the viability of BT474 breast ductal carcinoma cells after transfection. The migration of BT474 breast ductal carcinoma cells was examined by cell wound scratch assay. @@@ Results @@@ In addition, the protein expression of C35, HER2, AKT and p-AKT in breast ductal carcinoma cells were detected by Western Blot. The protein expression of C35 was weaker in siRNA1 and siRNA2 groups compared with the control group. The relative expression ratio of C35 to beta-actin decreased significantly in siRNA2 and siRNA1 groups. When C35 expression was interfered by siRNA1 and siRNA2 for 48 h, the viability of BT474 breast ductal carcinoma cells decreased compared with the control group. In addition, the migration of breast ductal carcinoma cells decreased when C35 expression was interfered by siRNA1 for 24 h, and interfered by siRNA1 and siRNA2 for 48 h.

• 出版日期2017-8-31
• 单位复旦大学